Tham khảo Dapoxetine

  1. ↑ “Russian State Register of Medicines. Priligy (dapoxetine) Film-coated Tablets, for Oral Use. Full Prescribing Information” (bằng tiếng Nga). 25 tháng 7 năm 2013. Truy cập ngày 11 tháng 8 năm 2016.  Bảo trì CS1: Ngôn ngữ không rõ (link)
  2. 1 2 Dresser, M. J.; Desai, D.; Gidwani, S.; Seftel, A. D. & Modi, N. B. (2006). “Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors”. International Journal of Impotence Research 18 (1): 104–110. doi:10.1038/Sj.Ijir.3901420. 
  3. ↑ McMahon, CG (tháng 10 năm 2012). “Dapoxetine: a new option in the medical management of premature ejaculation.”. Therapeutic advances in urology 4 (5): 233–51. PMC 3441133. PMID 23024705. doi:10.1177/1756287212453866. 
  4. 1 2 Government, A. (2010). Australian Public Assessment Report for Dapoxetine (D. o. H. a. A. T. G. Administration, Trans.).
  5. 1 2 3 Andersson, K. E.; Mulhall, J. P. & Wyllie, M. G. (2006). “Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation.”. BJU International 97 (2): 311–315. doi:10.1111/J.1464-410x.2006.05911.X. 
  6. ↑ McCarty, E. & Dinsmore, W. (2012). “Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation”. Core Evid 7: 1–14. PMC 3273363. doi:10.2147/CE.S13841. 
  7. ↑ http://www.menarini.com/news/News-Archive/20122/Morrisville-N.C.-and-Florence-Italy-May-14-2012-NEWS-RELEASE
  8. ↑ McMahon, C. G.; McMahon, C. N.; Leow, L. J. (2006). “New agents in the treatment of premature ejaculation”. Neuropsychiatr Dis Treat 2 (4): 489–503. PMC 2671940. PMID 19412497. doi:10.2147/nedt.2006.2.4.489. 
  9. ↑ Pryor, J. L.; Althof, S. E.; Steidle, C.; Rosen, R. C.; Hellstrom, W. J. G.; Shabsigh, R.; Kell, S. (2006). “Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomized controlled trials”. Lancet 368 (9539): 929–937. PMID 16962882. doi:10.1016/s0140-6736(06)69373-2. 
  10. ↑ Shabsigh, R.; Broderick, G. A.; Miloslavsky, M.; Bull, S. (2006). “Dapoxetine has long-term efficacy in the treatment of premature ejaculation”. Journal of Urology 175 (4): 297–298. 
  11. ↑ Montague, D. K.; Jarow, J.; Broderick, G. A.; Dmochowski, R. R.; Heaton, J. P.; Lue, T. F.; Sharlip, I. D. (2004). “AUA guideline on the pharmacologic management of premature ejaculation. [Guideline Practice Guideline]”. J Urol 172 (1): 290–294. doi:10.1097/01.ju.0000132159.61156.ea. 
  12. ↑ Contraindications. (2012) Retrieved 11/27, 2012, from https://www.drugs.com/enc/contraindications.html
  13. ↑ Buvat, J.; Tesfaye, F.; Rothman, M.; Rivas, D. A.; Giuliano, F. (2009). “Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries”. European Urology 55 (4): 957–968. doi:10.1016/J.Eururo.2009.01.025. 
  14. ↑ (tiếng Pháp) (2013) « Éjaculation précoce: pas de dapoxétine » http://www.prescrire.org/fr/3/31/48533/0/NewsDetails.aspx
  15. ↑ McMahon, C. G.; Kim, S. W.; Park, N. C.; Chang, C. P.; Rivas, D.; Tesfaye, F.; Aquilina, J. W. (2010). “Treatment of Premature Ejaculation in the Asia-Pacific Region: Results from a Phase III Double-blind, Parallel-group Study of Dapoxetinejsm_1560256..268”. J Sex Med 7. doi:10.1111/j.1743-6109.2009.01560.x. 
  16. ↑ Montejo, A. L.; Llorca, G.; Izquierdo, J. A.; Rico-Villademoros, F.; Psychotr, S. W. G. S. (2001). “Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients”. Journal of Clinical Psychiatry 62: 10–21. 
  17. ↑ Jhanjee, A.; Kumar, P.; Bhatia, M. S.; Srivastava, S. (2011). “Dapoxetine-A Novel Drug for Premature Ejaculation”. Delhi Psychiatry Journal 14 (1): 5. 
  18. 1 2 Modi, N. B.; Dresser, M.; Desai, D.; Jazrawi, R. P. (2005). “Dapoxetine for the treatment of premature ejaculation: Lack of interaction with ethanol”. Journal of Urology 173 (4): 239–239. 
  19. ↑ Gengo, P. J.; View, M.; Giuliano, F.; McKenna, K. E.; Chester, A.; Lovenberg, T.; Gupta, S. K. (2005). “Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation”. Journal of Urology 173 (4): 239–239. 
  20. ↑ Goldstein, I. (2003, 11/17/12). The Central Mechanisms of Sexual Function Retrieved 11/11/12, 2012, from http://www.bumc.bu.edu/sexualmedicine/publications/the-central-mechanisms-of-sexual-function/
  21. ↑ Giuliano, F.; Clement, P. (2005). “Physiology of ejaculation: emphasis on serotonergic control. [Review]”. Eur Urol 48 (3): 408–417. doi:10.1016/j.eururo.2005.05.017. 
  22. ↑ Clement, P.; Bernabe, J.; Gengo, P.; Denys, P.; Laurin, M.; Alexandre, L.; Giuliano, F. (2007). “Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine”. European Urology 51 (3): 825–832. doi:10.1016/J.Eururo.2006.10.011. 
  23. ↑ McMahon, C. G.; Althof, S. E.; Kaufman, J. M.; Buvat, J.; Levine, S. B.; Aquilina, J. W.; Porst, H. (2011). “Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. [Meta-Analysis Research Support, Non-U.S. Gov't].”. J Sex Med 8 (2): 524–539. PMID 21059176. doi:10.1111/j.1743-6109.2010.02097.x. 
  24. ↑ Dapoxetine: a guide to its use in premature ejaculation (D. T. Perspective, Trans.). (2011) (Vol. 27, pp. 1-4).
  25. ↑ Dresser, M.; Lindert, K.; Lin, D.; Gidwani, S.; Gupta, S. K.; Modi, N. B. (2004). “Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers”. Clinical Pharmacology & Therapeutics 75 (2): P32. doi:10.1016/J.Clpt.2003.11.123. 
  26. ↑ Kowey, P. R.; Mudumbi, R. V.; Aquilina, J. W.; DiBattiste, P. M. (2011). “Cardiovascular safety profile of dapoxetine during the premarketing evaluation. [Research Support, Non-U.S. Gov't].”. Drugs in R&D 11 (1): 1–11. PMC 3585760. doi:10.2165/11587660-000000000-00000. 
  27. ↑ Khan, A.; Khan, S.; Kolts, R.; Brown, W. A. (2003). “Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports”. American Journal of Psychiatry 160 (4): 790–792. PMID 12668373. doi:10.1176/Appi.Ajp.160.4.790. 
  28. ↑ Tamam, L.; Ozpoyraz, N. (2002). “Selective serotonin reuptake inhibitor discontinuation syndrome: A review”. Advances in Therapy 19 (1): 17–26. PMID 12008858. doi:10.1007/Bf02850015. 
  29. ↑ McMahon, C. G. (2012). “Dapoxetine: a new option in the medical management of premature ejaculation”. Ther Adv Urol 4 (5): 233–251. PMC 3441133. PMID 23024705. doi:10.1177/1756287212453866. 
  30. 1 2 Hellstrom WJ (2009). “Emerging treatments for premature ejaculation: focus on dapoxetine”. Neuropsychiatr Dis Treat 5: 37–46. PMC 2695237. PMID 19557098. doi:10.2147/ndt.s3251. 
  31. ↑ Owen RT (2009). “Dapoxetine: a novel treatment for premature ejaculation”. Drugs Today 45 (9): 669–78. PMID 19956808. doi:10.1358/dot.2009.45.9.1388694. 
  32. ↑ Waldinger, M. D. (2007). “Premature ejaculation — Definition and drug treatment”. Drugs 67 (4): 547–568. doi:10.2165/00003495-200767040-00005. 
  33. ↑ Venkatesan, K., & Srinivasan, K. V. (2008). A stereoselective synthesis of (S)-dapoxetine starting from trans-cinnamyl alcohol. arkivoc, 16, 9.

Liên quan

Tài liệu tham khảo

WikiPedia: Dapoxetine http://www.chemspider.com/Chemical-Structure.64453... http://www.drugs.com/international/dapoxetine.html http://www.menarini.com/news/News-Archive/20122/Mo... http://www.bumc.bu.edu/sexualmedicine/publications... //www.ncbi.nlm.nih.gov/pmc/articles/PMC2671940 //www.ncbi.nlm.nih.gov/pmc/articles/PMC2695237 //www.ncbi.nlm.nih.gov/pmc/articles/PMC3273363 //www.ncbi.nlm.nih.gov/pmc/articles/PMC3441133 //www.ncbi.nlm.nih.gov/pmc/articles/PMC3585760 //www.ncbi.nlm.nih.gov/pubmed/12008858